Delivery Order SPE2DB20D1004-SPE2DB25FNJQF
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,463.20 for Insulin Aspart 100 Unit/mL vials (10mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) with a ceiling value of $2,262.05. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,436,064 units of Insulin Aspart 100 unit/mL vials. The contract has a potential value of $5,426.62 and a completion date of January 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.21, is for the delivery of insulin aspart 100 unit/mL pen 3mL. The contract has a completion date of June 27, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
- This federal contract award, valued at $2,582.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/ML Vial (10 ML), a critical medication for diabetes management. This contract is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order (SPE2DB20D1100|SPE2DB24FA7V6) for the supply of 4563997038 - INSULIN ASPART 100 UNIT/ML PEN 3ML, with an ultimate completion date of March 19, 2024 and a ceiling value of $2,963.28. AmerisourceBergen Drug Corp holds an...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,299,186 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $3,659.20 delivery order has a completion date of January 11, 2024. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contract awards from the DLA to supply pharmaceuticals, medical...